Clin2
NCT06413212Possibly a fitRecruiting

Personalized drug test for advanced cancer with fluid buildup

Lung CancerBreast CancerGastric CancerColorectal Cancer

Part of Cancer, Digestive system, Lungs & breathing, Skin clinical trials.

This trial uses a special test on your cancer cells to find which chemotherapy might work best for you. The aim is to treat advanced cancer that has caused fluid buildup in the chest or abdomen.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
55 people
Ages
18 years and older
Study type
Observational

Who can take part

  • You must be between 18 and 75 years old.
  • You have advanced cancer that cannot be removed by surgery and has spread to cause fluid buildup in the chest or belly.
  • Standard treatments have stopped working or caused too many side effects.
  • You are well enough to walk around and take care of yourself (ECOG score 0-2).
  • Your doctor expects you to live at least 6 more months.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07500259Recruiting
Personalized drug testing for GI tumors

This trial uses a lab test to see how your tumor responds to different drugs, helping doctors choose the best treatment for you. It is for people with pancreatic cancer (PDAC) who are having surgery or a biopsy.

Luxembourg, Luxembourg
NCT02906943Recruiting
Testing cancer tissue to guide targeted treatment choices

This trial studies advanced solid tumors by using stored tumor samples to look for molecular clues. The goal is to help doctors better choose cancer treatments that may work for your specific tumor.

Hamilton, Ontario
NCT03356808Not yet recruiting· Phase 1/Phase 2
T cells for advanced lung cancer

This trial tests a personalized treatment using your own immune cells (T cells) that are specially trained to find and attack lung cancer cells. It may help people with advanced or relapsed lung cancer who have not improved with standard treatments.

Shenzhen, Guangdong
NCT02732860Recruiting
Test your tumor’s drug response using a lab model

This trial grows a lab model from your own tumor tissue (or resected tissue) to predict which drugs might work best. It’s meant to match investigational treatments to your specific tumor biology.

Toronto, Ontario
NCT06077591Recruiting
Genetic and organoid testing to guide cancer treatment

This trial uses advanced testing (genetic sequencing and lab-grown tumor models) to find the best treatment for people with advanced solid tumors that haven't responded to at least one standard treatment. The goal is to personalize therapy based on your tumor's unique features.

Hong Kong, N.T.
NCT07328945Recruiting
Personalized treatment for non-small cell lung cancer using a tumor model

This trial tests a new way to choose the best treatment for your lung cancer by creating a model of your tumor in the lab. It may help doctors find the most effective therapy for you.

Shanghai, Shanghai Municipality

Hear when a new Lung cancer trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.